Showing results (81-90 of 115) with videos related to
Sort By:
Pageof 12
European Heart Journal|January 1, 1997
Low total cholesterol is associated with high total mortality in patients with coronary heart disease. The Bezafibrate Infarction Prevention (BIP) Study GroupS Behar, E Graff, H Reicher-Reiss, et al.Hormone Research|January 1, 1982
Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiencyA Rösler, E Leiberman, J Sack, et al.The American Journal of Cardiology|June 30, 1998
Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III. The Bezafibrate Infarction Prevention (BIP) Study GroupM Haim, A Shotan, V Boyko, et al.Cardiovascular Diabetology|November 25, 2003
Increased prevalence of left ventricular hypertrophy in hypertensive women with type 2 diabetes mellitusAlexander Tenenbaum, Enrique Z Fisman, Ehud Schwammenthal, et al.European Journal of Endocrinology|December 31, 2005
Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucoseHilla Knobler, Michal Benderly, Valentina Boyko, et al.Journal of the American Heart Association|April 17, 2024
Arrhythmia Burden Among Adult Patients With Congenital Heart Disease: A Population-Based StudyNili Schamroth Pravda, Ofra Kalter-Leibovici, Amiram Nir, et al.Coronary Artery Disease|July 18, 2006
Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudyMoti Haim, Michal Benderly, Valentina Boyko, et al.European Journal of Pharmacology|December 3, 1981
Interactions of beta-carbolines with the benzodiazepine receptor: structure-activity relationshipsH A Robertson, G B Baker, R T Coutts, et al.Cardiology|February 7, 2007
C-reactive protein distribution and correlates among men and women with chronic coronary heart diseaseM Benderly, M Haim, V Boyko, et al.European Journal of Neurology|June 23, 2009
Increased insulin resistance and risk of incident cerebrovascular events in patients with pre-existing atherothrombotic diseaseD Tanne, A Tenenbaum, V Boyko, et al.Pageof 12